Morningstar Investment Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,040	Closed	-$481K	–	394
2024 Q3	$481K	Buy	1,040 +11	+1%	+$5.09K	﹤0.01%	276
2024 Q2	$486K	Buy	1,029 +379	+58%	+$179K	0.01%	255
2024 Q1	$271K	Sell	650 -312	-32%	-$130K	﹤0.01%	300
2023 Q4	$394K	Buy	+962	New	+$394K	﹤0.01%	314